Skip to content

NCI Payline 2026: No Cutoff, Budget Cuts, R01 Odds

Updated 7 official sources

Quick Answer: NCI has no FY2026 payline. Its policy says NCI "no longer uses paylines to determine competing grant funding selections." It does publish budget cuts: new R01s above $250,000 in direct costs are funded 17% below the study section's recommended level.

Full answer and how we checked it

NIH's Data Book shows NCI funded 6.9% of new R01 applications in FY2025 (432 of 6,278). A Grantsights pull of NIH RePORTER found 806 new NCI R01 and R37 awards in FY2026, up from 499.

This guide is for: cancer researchers looking up the NCI payline, deciding whether an R01 or R21 budget will survive NCI's FY2026 reductions, or comparing NCI's odds with other institutes after a weak FY2025.

Data note: Policy text is from NCI's FY2026 funding policies page on grants.nih.gov, read October 1, 2026. Success rates are from NIH Data Book table 206 (data last updated February 18, 2026) and table 217. Award counts, project lengths, first-year direct costs and notice dates are from a Grantsights pull of the NIH RePORTER API on October 1, 2026 (administering institute NCI, activity codes R01 and R37, award types 1 and 2, fiscal years 2024-2026). The same query can be rerun in NIH RePORTER.

In this guide

To compare NCI with every other institute, the NIH and NSF funding odds tracker puts each institute's FY2026 policy and its FY2021-FY2025 success rates side by side, with a CSV.

For years, NCI's percentile cutoff was the number cancer researchers tracked most closely. That number is gone. What NCI does publish now is arguably more useful for planning: exactly how much it trims each kind of new award. This page puts that policy next to NCI's funding odds and its FY2026 award record.

From Manusights, our sister product

Applying for an R01 or R21? Manusights offers an AI critique of your application against NIH's published review criteria: $149 for a new R01 or R21, $199 for a resubmission. Back within 3 business days of your upload.

Order a grant review

NCI Payline Status: Selection Without a Cutoff

According to the NCI FY2026 funding policies (opens in a new tab), after study section review and the National Cancer Advisory Board, NCI's scientific leaders and program staff consider 7 factors:

NCI selection factor (FY2026)What to do about it
Scientific meritStill the starting point; your score carries weight
Public health significanceState the cancer burden or patient impact in plain numbers
Scientific noveltyShow what changes if the aims succeed
Representation of the topic in NCI's portfolioCheck RePORTER for how crowded your area is
Investigator career stageConfirm ESI status before review
Total NCI funding already held by the investigatorExpect a higher bar for well-funded labs
Availability of NCI fundsTiming within the fiscal year matters

NCI adds that it may fund applications that address gaps in cancer research or propose work "that may be difficult to evaluate through peer review," and that it doesn't use predetermined targets for disease areas. NCI's page also notes that NIH is under a continuing resolution through December 11, 2026, so FY2027 terms can still change. The NIH paylines guide explains how this no-cutoff model works across institutes.

Get research funding calls by email

About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.

No spam. Unsubscribe anytime.

NCI Budget Reductions in FY2026

This is the part of NCI's policy that's specific enough to plan around. Reductions apply to the study section's (Initial Review Group's) recommended level:

FY2026 NCI application typeReduction from recommended level
New R01 or U01, more than $250,000 direct in any budget period17%
New R01 or U01, $250,000 or less, and more than $175,0008.5%
New R01 or U01, $175,000 or less6.5%
New R21, more than $175,0008.5%
New R21, $175,000 or less6.5%
New P01, UM1 or R33, more than $175,00017%
New P01, UM1 or R33, $175,000 or less13%
Competing renewals (Type 2) of R01, U01, P01, UM1, R33NCI Type 2 cap, no added cut

Grantsights worked the arithmetic for three common requests:

Requested direct costs per yearTierExpected award direct costs
$300,000 (new R01)Over $250,000$249,000
$225,000 (new R01)$175,001-$250,000$205,875
$150,000 (new R01)$175,000 or less$140,250

The common mistake is building a $300,000 R01 whose aims need every dollar. At a 17% cut, the lab gets $249,000. Plan the staffing for the post-cut number, and keep one aim that can shrink without breaking the project.

Why $250,000 Is the Line That Matters

NCI's 17% tier starts above $250,000 in direct costs in any budget period. That's the same ceiling NIH uses for modular budgets, which cover requests of up to $250,000 a year in $25,000 modules. So the policy splits NCI's new R01s into two groups:

Budget formatDirect costs per yearFY2026 NCI cut on a new R01
Modular, 7 modules or fewer$175,000 or less6.5%
Modular, 8 to 10 modules$200,000-$250,0008.5%
Detailed budgetAbove $250,000 in any year17%

A single year above $250,000, for example an equipment purchase in year 1, moves the whole award into the 17% tier. Grantsights reads the policy as an incentive to keep year-one spikes out of a detailed budget when a modular request would cover the science. The modular budget guide explains the module rules.

NCI R01 Success Rates: FY2021 to FY2025

NIH's success-rate tables (opens in a new tab) show NCI's R01 odds fell harder in FY2025 than at most institutes.

Fiscal yearNew R01 applications / awardsNew success rateRenewal success rateAll R01 success rate
FY20215,807 / 69612.0%31.7%12.9%
FY20225,379 / 69112.8%31.6%13.8%
FY20235,221 / 72213.8%32.1%14.6%
FY20245,499 / 58410.6%29.1%11.4%
FY20256,278 / 4326.9%19.7%7.3%

Source: NIH Data Book table 206; "all R01" sums new, renewal and revision rows. New applications rose by 779 in FY2025 while new awards fell by 152. Across all research project grants, NIH's table 217 shows NCI at 9.6% in FY2025, against 13.7% in FY2024.

For example, NCI received 6,278 new R01 applications in FY2025, about 1.7 times NIAID's 3,613. Grantsights compared the four institutes' FY2025 new-application rates in table 206:

InstituteNew R01 applications, FY2025New R01 success rate
NCI6,2786.9%
NIDDK2,8239.0%
NIAID3,61312.8%
NHLBI4,09414.6%

According to NIH, the NIH-wide R01-equivalent success rate was 13.0% in FY2025, so NCI's new-application odds were roughly half the average.

Why this page reports R01 alone: NIH's table also lists NCI R37 awards (115 in FY2025), each counted as both an application and an award, so they show a 100% rate. Adding them lifts NCI's FY2025 figure to 9.0% without changing anyone's real odds.

The R21 isn't a refuge either. NCI funded 163 of 1,990 R21 applications in FY2025 (8.2%), down from 206 of 1,696 (12.1%) in FY2024.

What NCI's FY2026 Award Record Shows

FY2026 NCI success rates aren't out yet. Grantsights pulled every FY2026 NCI R01 and R37 competing award from RePORTER on October 1, 2026:

NCI competing R01/R37 award recordsFY2024FY2025FY2026
New (Type 1)647499806
Competing renewal (Type 2)654573
New awards paid up front (multi-year funded)04612
New awards with five-year project periods603423759

That's the largest count of new NCI R01 awards in the three years, and it follows the 1% NIH appropriation increase that, according to NIH's FY2026 fiscal policy notice (opens in a new tab), was targeted in part to cancer. It's an award-side funding trend. If applications stayed near FY2025's 6,278, 806 new awards would still put the new-application rate near 13%, close to FY2022-FY2023 levels.

NCI also kept five-year R01s. In FY2026, 759 of 806 new awards ran five years, unlike NHLBI, where four-year awards are the default.

Award Size After the Cuts

RePORTER shows what NCI paid, after any reduction. For new awards paid one budget year at a time:

New NCI R01/R37, single-year budgetsFY2024FY2025FY2026
Median first-year direct cost$384,077$406,778$413,900
Median total award (direct plus indirect)$590,094$621,570$640,290
Awards under $500,000 direct570 of 646391 of 453677 of 794

Most funded NCI R01s sit above $250,000 in direct costs, the tier that takes the 17% cut. If a median award of $413,900 had been cut 17%, the request behind it would have been about $498,700. Award records can't confirm individual requests, but the gap is a reminder to read the Notice of Award before hiring.

When NCI Awards Arrive

FY2026 new NCI R01 and R37 award notices peaked in summer: 162 in June, 174 in July, 135 in August and 117 in September. FY2025 had an early cluster instead, with 108 notices in December 2024. Timing varies by year and council round, so a quiet spring isn't a signal.

What NCI's Policy Page Doesn't Tell You

SourceWhat it gives youWhat it leaves out
NCI FY2026 policy pageSelection factors and exact budget cutsAny score or percentile that predicts selection
NIH Data BookOfficial new and renewal success ratesFY2026 and percentile bands
NIH RePORTERAwards after cuts, lengths, notice monthsUnfunded applications and original requests

The honest read: without a payline, a 10th-percentile NCI score in FY2026 is a strong application, not a funded one. The investigator-funding factor is the one most applicants overlook. A PI with several active NCI awards should expect a higher bar than an ESI with the same score.

Submit, Resize, or Switch: Decision Table

Your situationBest next action
New R01 planned near $260,000 directModel both tiers; at $250,000 the cut is 8.5%, above it 17%
R21 chosen because it seems easierSkip that logic; NCI's FY2025 R21 rate was 8.2%
Scored FY2025 A0 that missedResubmit; FY2026 new-award counts rose to 806
Renewal coming dueRenewals avoid the added cut; submit with time for one A1
ESI applicantConfirm ESI status; career stage is a listed factor

Use the summary statement guide and the resubmission guide for the A1. Compare odds with the NIAID R01 success-rate page and the NIDDK payline page, and search cancer-related funding beyond NCI in Grantsights grant search.

Sources

Frequently Asked Questions

What is the NCI payline for 2026?

NCI no longer has one. Its FY2026 funding policy says that, in alignment with NIH funding policies, NCI no longer uses paylines to determine competing grant funding selections. Scientific leaders and program staff weigh merit, public health significance, novelty, portfolio representation, career stage, existing NCI funding and available funds.

How much does NCI cut new R01 budgets?

Under the FY2026 policy, a new R01 with more than $250,000 in direct costs in any budget period is generally funded 17% below the study section's recommended level. New R01s at or under $250,000 are cut 6.5% when at or under $175,000 and 8.5% when above it. Competing renewals are funded at the NCI Type 2 cap with no added reduction.

What was the NCI R01 success rate in FY2025?

NIH Data Book table 206 shows NCI funded 432 of 6,278 new R01 applications in FY2025 (6.9%) and 47 of 239 renewals (19.7%). Counting all R01 applications, the rate was 7.3%, down from 11.4% in FY2024 and 14.6% in FY2023.

What is the NCI R21 success rate?

NIH's table shows NCI funded 163 of 1,990 R21 applications in FY2025, an 8.2% success rate, down from 12.1% in FY2024. New R21s are also cut 6.5% or 8.5% from the recommended level under the FY2026 policy.

Did NCI fund more R01s in FY2026?

The award record says yes. A Grantsights pull of NIH RePORTER on October 1, 2026 found 806 new NCI R01 and R37 awards in FY2026, against 499 in FY2025 and 647 in FY2024. NIH hasn't published FY2026 application counts, so the success rate isn't known yet.

Last updated October 1, 2026. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.